Please assess the completion status of the following clinical trial:

Trial Title: Fibrin Glue in Inguinal Lymphadenectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~• Patients scheduled to perform ILND for various causes~Exclusion Criteria:~* BMI more than 35,~* Uncompensated diabetes~* Advanced liver disease~* Previous history of surgery and/or irradiation to the inguinal region~* Preoperative chemotherapy~* Significant coagulation disorders~* Platelet counts \<100,000/mL.~* Use of systemic steroids or anticoagulants.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fibrin glue (Type: EXPERIMENTAL): A fibrin glue was applied to the lymphadenectomy bed before wound closure and insertion of a drain.
- Control (Type: NO_INTERVENTION): Lymphadenctomy wound was closed after insertion of a drain,

Based on this trial design, predict the completion outcome and termination type (if applicable).